Skip to main content
. 2022 Jul 15;14(7):e26905. doi: 10.7759/cureus.26905

Table 5. Association of the clinical, laboratory and baseline characteristics with the GI lesions among the study subjects.

BMI: Body mass index, NSAID: Non-steroidal anti-inflammatory drugs, PPI: Proton pump inhibitor, GI: Gastrointestinal, MCV: Mean corpuscular volume

Variables GI lesion [Number (%)] P value
Yes (n=99) No (n=53)
Age
<50 years 26 (26.3) 29 (54.7) 0.0005
>50 years 73 (73.7) 24 (45.3)
BMI (kg/m2) 23.1 ± 5.2 20.3 ± 4.1 0.0009
Diet
Vegetarian 58 (58.6) 40 (75.5) 0.038
Mixed 41 (41.4) 13 (24.5)
History of medication
NSAID 6 (6.1) 3 (5.7) 0.920
PPI 19 (19.2) 3 (5.7) 0.028
Comorbidities
No 57 (57.6) 32 (60.4) 0.738
Yes 42 (42.4) 21 (39.6)
Any GI symptoms
Yes 75 (75.8) 26 (49.1) 0.008
No 24 (24.2) 27 (50.9)
Haematological
Haemoglobin (g/dL) 8.6 ± 1.7 10.2 ± 1.4 <0.0001
MCV (fL) 74.9 ± 8.2 75.6 ± 7.8 0.610
Ferritin (ng/ml) 6.3 ± 5.7 5.9 ± 4.3 0.655
Transferrin (g/L) 8.3 ± 2.9 7.7 ± 3.5 0.260
Faecal
Occult Blood 25 (25.3) 31 (58.5) <0.0001
Parasites/Ova/Cysts 6 (6.1) 15 (28.3) 0.0001